Skull bone marrow harbors rapid-response immune hubs against brain tumors
Researchers discovered lymph node-like immune structures in the skull bone marrow of mice that respond quickly to brain cancer. These local hubs activate before distant lymph nodes, and strengthening them improved tumor rejection and survival. Similar immune cells were found in human skull bone marrow, suggesting the defense system may exist in people.
The research team, led by Jonathan Kipnis at Washington University School of Medicine, published their findings in Nature. They tracked proteins moving from brain tissue through physical channels into skull bone marrow, where they found organized immune structures resembling lymph nodes—a discovery never before seen in healthy bone marrow.
Using a glioblastoma mouse model, the researchers found these skull-based immune hubs activated before distant lymph nodes. Strengthening these local defenses improved tumor rejection and survival. Similar immune cells were identified in human skull bone marrow, suggesting this rapid-response defense system may exist in people and could potentially be targeted for new brain cancer treatments.
This discovery could reshape how brain cancer is approached clinically, potentially leading to therapies that strengthen skull-based immune hubs rather than relying on systemic treatments. Patients with glioblastoma and other brain tumors may eventually benefit from more targeted, faster-acting immune interventions. The findings may also influence research into other neurological conditions, though human applications remain years away and require further validation.